In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)


The Latest

Filters

Bumbu Rum

Ad Alert

Bumbu Rum

Lawsuit alleges beverage doesn’t meet federal standards to be marketed as rum.

Lomi

Ad Alert

Lomi

TINA.org digs into company’s broad composting claims.

TruHeight

Ad Alert

TruHeight

Company marketing ‘height growth vitamins’ makes some tall claims.


Show More